Vivo Bio Tech Ltd — Others, 26-08-2025: Others

Vivo Bio Tech's Board has approved key corporate actions. The 38th Annual General Meeting is scheduled for September 30, 2025, to be held virtually. The Board also approved its Report for the financial year ended March 31, 2025. Dr. Sankaranarayanan Alangudi was re-appointed as a director, retiring by rotation. Furthermore, the Board approved the appointment of Mr. Vinay Babu Gade as the Secretarial Auditor for five years (FY 2025-26 to FY 2029-30), subject to shareholder approval at the upcoming AGM. These approvals address important governance and compliance matters for the company.